跳至主要内容
临床试验/ISRCTN81956288
ISRCTN81956288已完成未知

The effect of n-3 polyunsaturated fatty acid (PUFA) supplementation in patients with steatosis due to non-alcoholic fatty liver disease

niversity of Nottingham (UK)0 个研究点目标入组 58 人开始时间: 2010年5月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age greater than 18 years, either sex
  • 2. Liver biopsy showing NAFLD

排除标准

  • 1. Excessive alcohol intake - greater than 21 units per week in men and greater than 14 in women
  • 2. A further liver disease diagnosis
  • 3. Poorly controlled diabetes - HbA1c greater than 8.0%
  • 4. Pregnancy
  • 5. Cirrhosis
  • 6. Significant inflammation on liver biopsy - classified as a Brunt moderate or severe
  • 7. Life expectancy of less than 2 years
  • 8. Contraindications to MR scanning - pacemaker or metallic foreign body
  • 9. Changes in the dose or initiation of lipid altering medication within the preceeding three months, such as statins, fibrates or systemic steroids
  • 10. Use of n-3 PUFA supplements within the prior 4 months, an adequate washout period

研究者

发起方
niversity of Nottingham (UK)

相似试验